De novo drug design of a new copper chelate molecule acting as HIV-1 protease inhibitor

By Lebon F.   de Rosny E.   Reboud-Ravaux M.   Durant F.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 9, 1998-09 ,pp. : 733-737

Elsevier

Access to resources Recommend Favorite

Approaches to the Design of Effective HIV-1 Protease Inhibitors

By  

Current Medicinal Chemistry, Vol. 7, Iss. 4, 2000-04 ,pp. : 455-477

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Design Targeting the Main Protease, the Achilles' Heel of Coronaviruses

By  

Current Pharmaceutical Design, Vol. 12, Iss. 35, 2006-12 ,pp. : 4573-4590

Bentham Science Publishers

Access to resources Recommend Favorite

Prospects for the Resistance to HIV Protease Inhibitors: Current Drug Design Approaches and Perspectives

By  

Current Pharmaceutical Design, Vol. 11, Iss. 24, 2005-01 ,pp. : 3077-3090

Bentham Science Publishers

Access to resources Recommend Favorite

Structure Based Drug Design for HIV Protease: From Molecular Modeling to Cheminformatics

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 10, 2007-01 ,pp. : 1030-1038

Bentham Science Publishers

Access to resources Recommend Favorite